LinaTech At 59th ASTRO

Nov 1, 2017

At 59th ASTRO. Blog body: Linatech LLC returned as an exhibitor (Booth 2523) to the 59th ASTRO, the well-known American Society for Radiation Oncology, following an overwhelming response at the AAPM exhibition earlier this year. Held in San Diego Convention Center from 24th to 27th, Sept, this year's conference drew over 11,000 visitors from around the world and featured several high-standard parallel tracks. The event provided an excellent opportunity for professionals in Radiation Oncology to gather, exchange ideas, and learn about new technologies.

As a leading manufacturer of medical devices and software in radiotherapy, Linatech LLC showcased its cutting-edge D2SRS, a precision radiotherapy product for stereotactic radiosurgery. It is highly effective in treating intracranial lesions and small tumors, addressing the issue of tiny tumor treatment for doctors and physicists. The system integrates micro-multi-leaf-collimator and cylinder cones with exceptional positioning accuracy and dose conformity, achieving a combination of intensity modulated radiation therapy (IMRT / VMAT) and stereotactic radiosurgery (SRS / SBRT). Linatech's D2SRS can perform high-dose irradiation during the implementation of SRS/SBRT, assuaging concerns about treatment accuracy. It can be widely used to treat craniofacial lung cancer, liver cancer, prostate cancer, pancreatic cancer, brain cancer, and other radical treatments.

Linatech's D2SRS is made up of various components, including micro-multi-leaf-collimator (TiGRT MLC-CC51), radiotherapy planning system (TiGRT TPS), intelligent image-guided radiotherapy system (TiGRT IVS), iCK (intelligent Couch Kick), DVS (Dose Verification System with iQC phantom), iRV (Intelligent Record and Verification), and BPS (Binocular Positioning System). These integrated components ensure safe and accurate treatment with great convenience and efficiency.

To learn more, please contact us.